Find disease awareness content and relevant supporting materials

These updated 2025 BSG guidelines integrate recent advances in the management of inflammatory bowel disease, offering consensus‑based best practices to improve diagnostic pathways and clinical decision‑making. Developed through a rigorous methodology and broad expert input, they aim to enhance accuracy, timeliness, and international applicability in IBD care.

Guidelines: From MRI use to biopsy techniques

Researchers have identified a biomarker linked to schizophrenia that could lead to new treatments to tackle symptoms of the debilitating mental disorder not addressed by current medicines.

John Vissing on uncovering hidden MG symptoms

Read a transcript of John Vissing on MG questions clinicians can use to uncover unreported disease symptoms and align treatment expectations.

This updated ACG guideline addresses preventive care in inflammatory bowel disease, with recommendations on vaccinations, cancer screening, bone health, and infection prevention. It reflects advances in immunomodulatory therapies and emphasises the role of gastroenterologists in coordinated, proactive health maintenance.

This ACG clinical guideline provides evidence‑based recommendations for the diagnosis, monitoring, and treatment of Crohn’s disease in adults. Using the GRADE framework, it outlines preferred management strategies while supporting shared decision‑making and individualized care.